Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 12Neoplasms 6Stomach Neoplasms 3Pain, Postoperative 2Pain 2Motor Activity 2Lung Neoplasms 2Head and Neck Neoplasms 2Fatigue 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Sarcoma 1Psychological Well-Being 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Ovarian Neoplasms 1Lymphoma 1Lymphedema 1Lymphatic Metastasis 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Leukemia, Myeloid, Acute 1Leukemia 1Intellectual Disability 1Incisional Hernia 1Hot Flashes 1Hernia, Abdominal 1Heart Failure 1Health Behavior 1Esophageal Neoplasms 1

Interventions

Paclitaxel 6apatinib 4camrelizumab 3S 1 (combination) 2Capecitabine 2130-nm albumin-bound paclitaxel 2vorolanib 1titanium silicide 1spartalizumab 1raltitrexed 1olaparib 1lobaplatin 1durvalumab 1Ramucirumab 1Oxaliplatin 1Gastrectomy 1Docetaxel 1Control Groups 1Cisplatin 1CF regimen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Advanced Gastric Cancer × Control Groups × Clear all
NCT03449966 2019-01-11

Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy Status

Yonsei University

Phase NA Unknown
55 enrolled
Gastrointestinal

Advanced Gastric Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡